March 5, 2020 / 10:33 PM / a month ago

BRIEF-Caladrius Biosciences Reports Fourth Quarter And Full Year 2019 Financial Results

March 5 (Reuters) - Caladrius Biosciences Inc:

* CALADRIUS BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q4 LOSS PER SHARE $0.47

* AS OF DECEMBER 31, 2019, HAD CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $25.2 MILLION

* REMAINS CONFIDENT THAT CO’S CASH BALANCES WILL FUND ITS OPERATIONS THROUGH AT LEAST Q2 OF 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below